The Patent Finder

Opexa Pharmaceuticals

Also on record
Records under this name other than patents Opexa Pharmaceuticals holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 3 of 3 · Back to Opexa Pharmaceuticals

PatentTitleStatus Expires Confidence
US 7,744,893T cell receptor CDR3 sequences associated with multiple sclerosis and compositions comprising same
Lapsed on the fee record
Ended Jun 29, 2018 · High confidence
Lapsed on the fee recordEnded Jun 29, 2018High confidence
US 7,695,713Isolation and Identification of T Cells
Lapsed on the fee record
Ended Apr 13, 2018 · High confidence
Lapsed on the fee recordEnded Apr 13, 2018High confidence
US 7,658,926Autologous T-Cell Vaccines Materials and Methods
Formerly held
Lapsed on the fee record
Ended Feb 9, 2018 · High confidence
Lapsed on the fee recordEnded Feb 9, 2018High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited